{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:50:57Z","timestamp":1788565857517,"version":"build-2803163510"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,9]],"date-time":"2014-08-09T00:00:00Z","timestamp":1407542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00246-014-0978-3","type":"journal-article","created":{"date-parts":[[2014,8,8]],"date-time":"2014-08-08T11:48:30Z","timestamp":1407498510000},"page":"146-150","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Flecainide Use in Children with Cardiomyopathy or Structural Heart Disease"],"prefix":"10.1007","volume":"36","author":[{"given":"Brady S.","family":"Moffett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago O.","family":"Valdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caridad","family":"delaUz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Krenek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,9]]},"reference":[{"issue":"8","key":"978_CR1","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2174\/138161208784007716","volume":"14","author":"R Bouhouch","year":"2008","unstructured":"Bouhouch R, El Houari T, Fellat I, Arharbi M (2008) Pharmacological therapy in children with nodal reentry tachycardia: when, how and how long to treat the affected patient. Curr Pharm Des 14(8):766\u2013769","journal-title":"Curr Pharm Des"},{"key":"978_CR2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","volume":"324","author":"DS Echt","year":"1991","unstructured":"Echt DS, Liebson PR, Mitchell LB et al (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the cardiac arrhythmia suppression trial. N Engl J Med 324:781\u2013788","journal-title":"N Engl J Med"},{"issue":"2","key":"978_CR3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0735-1097(91)90586-X","volume":"18","author":"FA Fish","year":"1991","unstructured":"Fish FA, Gillette PC, Benson DW (1991) Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. J Am Coll Cardio 18(2):356\u2013365","journal-title":"J Am Coll Cardio"},{"key":"978_CR4","doi-asserted-by":"crossref","first-page":"72a","DOI":"10.1016\/S0002-9149(97)89121-7","volume":"77","author":"JR Hopson","year":"1996","unstructured":"Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG (1996) Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. Am J Cardiol 77:72a\u201382a","journal-title":"Am J Cardiol"},{"issue":"3","key":"978_CR5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00128072-200002030-00002","volume":"2","author":"T Paul","year":"2000","unstructured":"Paul T, Bertram H, Bokenkamp R, Hausdorf G (2000) Supraventricular tachycardia in infants, children and adolescents: diagnosis, and parmacological and interventional therapy. Paediatr Drugs 2(3):171\u2013181","journal-title":"Paediatr Drugs"},{"issue":"6","key":"978_CR6","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/0002-8703(92)90081-6","volume":"124","author":"JC Perry","year":"1992","unstructured":"Perry JC, Garson A (1992) Flecainide acetate for treatment of tachyarrhythmias in children: review of world literature on efficacy, safety, and dosing. Am Heart J 124(6):1614\u20131621","journal-title":"Am Heart J"},{"issue":"7","key":"978_CR7","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/S0735-1097(99)00105-9","volume":"33","author":"JP Pfammatter","year":"1999","unstructured":"Pfammatter JP, Paul T (1999) Idiopathic ventricular tachycardia in infancy and childhood: a multicenter study on clinical profile and outcome. Working group on dysrhythmias and electrophysiology of the association for European pediatric cardiology. J Am Coll Cardiol 33(7):2067\u20132072","journal-title":"J Am Coll Cardiol"},{"key":"978_CR8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.hlc.2011.10.008","volume":"21","author":"A Pflaumer","year":"2012","unstructured":"Pflaumer A, Davis A (2012) Guidelines for the diagnosis and management of catecholaminergic polymorphic ventricular tachycardia. Heart Lung Circ 21:96\u2013100","journal-title":"Heart Lung Circ"},{"issue":"4","key":"978_CR9","doi-asserted-by":"crossref","first-page":"20B","DOI":"10.1016\/0002-9149(90)91287-G","volume":"65","author":"CM Pratt","year":"1990","unstructured":"Pratt CM, Moye LA (1990) The Cardiac Arrhythmia Suppression Trial: background, interim results and implications. Am J Cardiol 65(4):20B\u201329B","journal-title":"Am J Cardiol"},{"key":"978_CR10","doi-asserted-by":"crossref","unstructured":"Seslar SP, Garrison MM, Larison C, Salerno JC: A multi-institutional analysis of inpatient treatment for supraventricular tachycardia in newborns and infants. Pediatr Cardiol 2012; Epub","DOI":"10.1007\/s00246-012-0474-6"},{"key":"978_CR11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1056\/NEJM198908103210628","volume":"321","author":"The Cardiac Arrhythmia Suppression Trial","year":"1989","unstructured":"The Cardiac Arrhythmia Suppression Trial (1989) (CAST) Investigators, preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:405\u2013412","journal-title":"N Engl J Med"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-014-0978-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-014-0978-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-014-0978-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T18:07:15Z","timestamp":1565719635000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-014-0978-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,9]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["978"],"URL":"https:\/\/doi.org\/10.1007\/s00246-014-0978-3","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,9]]}}}